Tech Company Financing Transactions
AtaCor Medical Funding Round
On 9/19/2018, AtaCor Medical raised $8.8 million in Series A investment from aMoon Partners, Broadview Ventures and private investors.
Transaction Overview
Company Name
Announced On
9/19/2018
Transaction Type
Venture Equity
Amount
$8,800,000
Round
Series A
Investors
aMoon Partners (Lead Investor)
Broadview Ventures (Lead Investor) (Maria Berkman)
Proceeds Purpose
The investment will support the continued development of AtaCor's revolutionary extravascular substernal cardiac pacing system.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
635 Camino de los Mares 205
San Clemente, CA 92673
USA
San Clemente, CA 92673
USA
Phone
Website
Email Address
Overview
AtaCor Medical, Inc. is a developing the world's first implantable cardiac pacing system that doesn't require any wires (leads) or hardware to be placed inside or onto the heart. AtaCor's delivery tool can safely insert the custom lead, without any need for fluoroscopy or other medical imaging and can be used to delivery temporary and/or permanent pacing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Sanghera
Chief Medical Officer
Marty Burke
VP - General Counsel
Sean McGeehan
VP - Regulatory Affairs
Alan Marcovecchio
Browse more venture capital transactions:
Prev: 9/19/2018: AON3D venture capital transaction
Next: 9/19/2018: Public Goods venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs